Applications will open in October 2024.
Minoshima-Pappas Transformative Leadership Award
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) recognizes that field of nuclear medicine and molecular imaging is changing rapidly. In 2017, with the vision of Satoshi Minoshima, MD, PhD, then SNMMI President, with support by Virginia Pappas, CAE, SNMMI CEO, launched the SNMMI Value Initiative. The Value Initiative became the SNMMI’s strategic vision and roadmap for 2017-2022 working with all stakeholders including the SNMMI leadership, SNMMI members, industry, and other partners to advance the crucial role of nuclear medicine and molecular imaging to the medical community, regulators, patients, and the public.
The Value Initiative comprises six key areas related to the healthcare and organization’s work: Quality of Practice, Research and Discovery, Workforce Pipeline and Life-Long Learning, Advocacy, Outreach, and Organizational Strength and Stability.
Through the Value Initiative, the SNMMI was able to change the dynamics of the field. The efforts included, but not limited to, the production of high-quality Appropriate Use Criteria, the development and clinical implementation of new radiopharmaceuticals and the advancement of theranostics, support for the workforce pipeline encompassing from trainees to leadership, the best outreach program among imaging societies, advocacy efforts that have successfully expanded coverage for old and new services, and strengthened the SNMMI Board of Directors and initiated organizational restructuring. In addition, the campaign “SNMMI Value Initiative” has raised the largest amount of funds in the history of SNMMI.
Award Description:
Minoshima-Pappas Transformative Leadership Award will recognize an individual who has made transformative impact in the field and elevated the value of nuclear medicine and molecular imaging.
Award recipients must have initiated, developed, and successfully implemented unique and significant transformative value within the field of Nuclear Medicine and Molecular Imaging. Examples include high impact discovery and publication that have changed patient care, initiation of multi-national collaborative research, revolutionizing education methods, practice changing quality management, regulatory and/or legislative transformations, innovative outreach to patients and other stakeholders, and so on.
Award recipients will receive 1) a plaque and $5,000 and will be acknowledged in person at the SNMMI Annual Meeting and 2) receive an invitation to the subsequent year’s SNMMI Annual Meeting and an option to organize a “Transformative Leadership” session (a standard CE session) for the topic of the awardee’s choice.
Eligibility:
Nomination and Application Process
Selection Process